{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T05:04:31Z","timestamp":1749531871385},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Science & Technology Development Plan of Jilin Province","award":["20140520008JH"],"award-info":[{"award-number":["20140520008JH"]}]},{"name":"Science & technology Research Project of The Education Department of Jilin Province","award":["437"],"award-info":[{"award-number":["437"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Protein Expression and Purification"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.pep.2016.09.015","type":"journal-article","created":{"date-parts":[[2016,9,30]],"date-time":"2016-09-30T20:16:38Z","timestamp":1475266598000},"page":"28-34","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Characterization of NoV P particle-based chimeric protein vaccines developed from two different expression systems"],"prefix":"10.1016","volume":"130","author":[{"given":"Lu","family":"Fu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongjiao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haihong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaxin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhe","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianghui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pep.2016.09.015_bib1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.tim.2004.04.005","article-title":"Norovirus disease: changing epidemiology and host susceptibility factors","volume":"12","author":"Hutson","year":"2004","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.pep.2016.09.015_bib2","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1600-065X.2008.00680.x","article-title":"Norovirus pathogenesis: mechanisms of persistence and immune evasion in human populations","volume":"225","author":"Donaldson","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.pep.2016.09.015_bib3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1126\/science.286.5438.287","article-title":"X-ray crystallographic structure of the Norwalk virus capsid","volume":"286","author":"Prasad","year":"1999","journal-title":"Science"},{"issue":"Suppl 2","key":"10.1016\/j.pep.2016.09.015_bib4","doi-asserted-by":"crossref","first-page":"S317","DOI":"10.1086\/315576","article-title":"Structural studies of recombinant Norwalk capsids","volume":"181","author":"Venkataram Prasad","year":"2000","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.pep.2016.09.015_bib5","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.1128\/JVI.00219-07","article-title":"Structural basis for the recognition of blood group trisaccharides by norovirus","volume":"81","author":"Cao","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.pep.2016.09.015_bib6","doi-asserted-by":"crossref","first-page":"5340","DOI":"10.1128\/JVI.00135-08","article-title":"Structural basis for the receptor binding specificity of Norwalk virus","volume":"82","author":"Bu","year":"2008","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.pep.2016.09.015_bib7","first-page":"753","article-title":"Norovirus P particle, a novel platform for vaccine development and antibody production","volume":"85","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.pep.2016.09.015_bib8","article-title":"Noroviral P particle: structure, function and applications in virus\u2013host interaction","volume":"382","author":"Ming","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.pep.2016.09.015_bib9","doi-asserted-by":"crossref","first-page":"14017","DOI":"10.1128\/JVI.79.22.14017-14030.2005","article-title":"The p domain of norovirus capsid protein forms a subviral particle that binds to histo-blood group antigen receptors","volume":"79","author":"Tan","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.pep.2016.09.015_bib10","doi-asserted-by":"crossref","first-page":"e63269","DOI":"10.1371\/journal.pone.0063269","article-title":"Norovirus P particle efficiently elicits innate, humoral and cellular immunity","volume":"8","author":"Fang","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.pep.2016.09.015_bib11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.imlet.2015.09.002","article-title":"Norovirus P particle: an excellent vaccine platform for antibody production against Alzheimer's disease","volume":"168","author":"Fu","year":"2015","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.pep.2016.09.015_bib12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.pep.2016.01.003","article-title":"Establishment of a novel method without sequence modification for developing NoV P particle-based chimeric vaccines","volume":"121","author":"Li","year":"2016","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.pep.2016.09.015_bib13","doi-asserted-by":"crossref","first-page":"7670","DOI":"10.1016\/j.vaccine.2011.07.139","article-title":"A\u00a0candidate dual vaccine against influenza and noroviruses","volume":"29","author":"Xia","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.pep.2016.09.015_bib14","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.virol.2010.11.017","article-title":"Terminal modifications of norovirus P domain resulted in a new type of subviral particles, the small P particles","volume":"410","author":"Tan","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.pep.2016.09.015_bib15","doi-asserted-by":"crossref","first-page":"7322","DOI":"10.1128\/JVI.00233-06","article-title":"C-terminal arginine cluster is essential for receptor binding of norovirus capsid protein","volume":"80","author":"Tan","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.pep.2016.09.015_bib16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jsb.2012.01.005","article-title":"Structure, stability and dynamics of norovirus P domain derived protein complexes studied by native mass spectrometry","volume":"177","year":"2012","journal-title":"J.\u00a0Struct. Biol."},{"key":"10.1016\/j.pep.2016.09.015_bib17","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/intimm\/dxg049","article-title":"Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with \u03b2-amyloid","volume":"15","author":"Cribbs","year":"2003","journal-title":"Int. Immunol."},{"key":"10.1016\/j.pep.2016.09.015_bib18","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2217\/nnm.12.62","article-title":"Norovirus P particle: a subviral nanoparticle for vaccine development against norovirus, rotavirus and influenza virus","volume":"7","author":"Ming","year":"2012","journal-title":"Nanomedicine"}],"container-title":["Protein Expression and Purification"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046592816301942?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046592816301942?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T21:30:31Z","timestamp":1536355831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1046592816301942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":18,"alternative-id":["S1046592816301942"],"URL":"https:\/\/doi.org\/10.1016\/j.pep.2016.09.015","relation":{},"ISSN":["1046-5928"],"issn-type":[{"value":"1046-5928","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of NoV P particle-based chimeric protein vaccines developed from two different expression systems","name":"articletitle","label":"Article Title"},{"value":"Protein Expression and Purification","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pep.2016.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}